PARP-inhibitors in epithelial ovarian cancer: Actual positioning and future expectations.
Cancer Treat Rev. 2021 Sep;99:102255. doi: 10.1016/j.ctrv.2021.102255. Epub 2021 Jul 15.
Cancer Treat Rev. 2021.
PMID: 34332292
Review.